Research reveals atomic-level changes in ALS-linked protein

January 18, 2018, Brown University
The hnRNPA2 protein forms liquid droplets in a test tube as seen by light microscopy. These structures let the researchers test how disease mutations and functional modifications change the behavior of the proteins with atomistic detail. Credit: Veronica Ryan/Brown University

For the first time, researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone. Their findings appear in the journal Molecular Cell.

The long-term goal of the research is to target this with a drug or other therapy to prevent these diseases, said the study's senior author, Nicolas Fawzi of Brown University. "There is currently no therapy or cure for ALS and . We are pursuing new hypotheses and angles to fight these illnesses."

Many proteins connected with these diseases contain "low-complexity" domains or pieces. Compared to a cell's best-understood proteins, which are ordered and static in structure, low-complexity domains are squirmy and disordered. Instead of a rigid shape, these pieces of are flexible and float inside cells until cued into action.

In non-disease situations, low-complexity domains help proteins perform healthy functions, including assembling into liquid-like droplets, where important cellular processes, such as RNA processing, take place.

When low-complexity domains go awry, as in disease, they transform into inclusions, intractable and accumulating knots or clumps. In certain cancers, low-complexity domains are improperly attached to other proteins that may then incorrectly form droplets in cellular locations, leading to mis-regulated expression of genes, Fawzi said.

"We're trying to understand why they change behavior and aggregate, and how we can disrupt those processes," he said.

In the study, the researchers describe the microscopic physical interactions and chemical changes of proteins associated with several cellular functions, including disease forms, and how still-healthy cells could try to temper it.

"We show how small chemical changes—involving only a few atoms—lead to big changes in assembly and disease-associated aggregation," Fawzi said. "These interactions are more dynamic and less specific than previously thought. A molecule does not take just one shape and bind to one shape but a molecule is flexible and interacts in flexible ways."

Cells divide up their function within distinct cellular structures called organelles, which traditionally thought of as being encased by membranes. The researchers studied a protein, called hnRNPA2, which is mutated in disease. The protein collects in membrane-less organelles, where it may use its low-complexity to stick together, much in the way that water collects into droplets on the outside of a cold soda bottle on a humid summer day. Until the publication of this study, several mechanistic details of how the low-complexity domain of hnRNPA2 worked and how it changed into aggregates in disease were unknown.

Using (NMR) spectroscopy, computer simulations and microscopy, the researchers showed how disease mutations and arginine methylation, a functional modification common to a large family of proteins with low-complexity domains, altered the formation of the liquid droplets and their conversion to solid-like states in disease.

These findings explain several threads of research conducted over the last 20 years on the role of hnRNP family proteins in neuron function and neurodegeneration, said Fawzi, who is an assistant professor in the Department of Molecular Pharmacology, Physiology and Biotechnology.

Previously Fawzi and colleagues described the structure and biophysics of a related protein, how ALS-associated genetic flaws interfered with its proper function and behavior of another member of the protein family, causing it to aggregate. A separate study revealed a possible means of preventing those clumps from forming.

"Because these low-complexity domains are too flexible to be directly targeted by standard drugs, finding out how cells use and tame these domains is a potential route to stopping their unwanted assembly in disease," Fawzi says.

Explore further: Study shows how mutations disrupt ALS-linked protein

More information: Mechanistic View of hnRNPA2 Low-Complexity Domain Structure, Interactions, and Phase Separation Altered by Mutation and Arginine Methylation, Molecular Cell (2018). DOI: 10.1016/j.molcel.2017.12.022 , http://www.cell.com/molecular-cell/fulltext/S1097-2765(17)30979-6

Related Stories

Study shows how mutations disrupt ALS-linked protein

August 18, 2016
In amyotrophic lateral sclerosis, aggregates of the protein TDP-43 are almost always found in afflicted neurons and glial cells. Meanwhile, about 50 ALS-linked mutations are known to affect a particular region of TDP-43. ...

Scientists prevent neurodegeneration-associated protein clumping in lab study

August 8, 2017
Scientists report in a new study that by imitating a natural process of cells, they prevented the formation of protein clumps associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.

Dynamic switch for FUS proteinopathy

July 20, 2017
NUS biologists have discovered that dynamics of the FUS protein plays a key role in FUS proteinopathy that causes certain neurological diseases.

Recommended for you

Antidepressant restores youthful flexibility to aging inhibitory neurons in mice

August 20, 2018
A new study provides fresh evidence that the decline in the capacity of brain cells to change, called "plasticity," rather than a decline in total cell number may underlie some of the sensory and cognitive declines associated ...

Perinatal hypoxia associated with long-term cerebellar learning deficits and Purkinje cell misfiring

August 18, 2018
Oxygen deprivation associated with preterm birth leaves telltale signs on the brains of newborns in the form of alterations to cerebellar white matter at the cellular and the physiological levels. Now, an experimental model ...

Automated detection of focal epileptic seizures in a sentinel area of the human brain

August 17, 2018
Patients with focal epilepsy that does not respond to medications badly need alternative treatments.

Men and women show surprising differences in seeing motion

August 16, 2018
Researchers reporting in the journal Current Biology on August 16 have found an unexpected difference between men and women. On average, their studies show, men pick up on visual motion significantly faster than women do.

Brain response study upends thinking about why practice speeds up motor reaction times

August 16, 2018
Researchers in the Department of Physical Medicine and Rehabilitation at Johns Hopkins Medicine report that a computerized study of 36 healthy adult volunteers asked to repeat the same movement over and over became significantly ...

Newly identified role for inhibition in cerebellar plasticity and behavior

August 16, 2018
Almost everyone is familiar with the unique mixture of surprise and confusion that occurs after making a mistake during an everyday movement. It's a fairly startling experience—stumbling on a step or accidentally missing ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.